(Q58047533)
Statements
Phase IB study of low-dose intraperitoneal recombinant interleukin-2 in patients with refractory advanced ovarian cancer: rationale and preliminary report (English)
U Beller
A Chachoua
J L Speyer
J Sorich
M Dugan
L Liebes
1 September 1989